Related Experiment Video
Updated: Mar 20, 2026

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
Published on: June 12, 2017
Pompe Disease and Autophagy: Partners in Crime, or Cause and Consequence?
M Rodríguez-Arribas, J M Bravo-San Pedro, R Gómez-Sánchez
1Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBE-RNED). rosapolo@unex.es.
Abstract:
Pompe disease or glycogen storage disease type II (OMIM: 232300) is a lysosomal storage disorder resulting from a partial or total lack of acid alphaglucosidase, which may produce muscle weakness, gait abnormalities, or even death by respiratory failure. In the last decade, autophagy has been proposed as a mechanism involved in the severity of symptoms related to this disorder and as a potential therapeutic target to alleviate disease progression. This review summarizes the relationship between autophagy and Pompe disease, including what information has been recently discovered and what remains unclear.
Insights
Pompe disease, a lysosomal disorder, involves acid alpha-glucosidase deficiency. Autophagy is a key factor in Pompe disease symptoms and a potential therapeutic target for this condition.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- Pompe disease (glycogen storage disease type II) is a rare lysosomal storage disorder.
- It stems from deficient acid alpha-glucosidase activity, leading to glycogen accumulation.
- Symptoms range from muscle weakness and gait issues to fatal respiratory failure.
Purpose of the Study:
- To review the intricate relationship between autophagy and Pompe disease.
- To highlight recent discoveries concerning autophagy's role in Pompe disease.
- To identify current knowledge gaps regarding autophagy in this disorder.
Main Methods:
- Literature review of scientific publications.
- Analysis of studies investigating autophagy in Pompe disease models.
- Synthesis of current understanding of molecular mechanisms.
Main Results:
- Autophagy has emerged as a significant factor influencing Pompe disease severity.
- Modulating autophagy presents a promising therapeutic avenue for Pompe disease.
- Recent research has elucidated specific pathways linking autophagy to disease pathology.
Conclusions:
- Autophagy plays a critical role in the pathogenesis and progression of Pompe disease.
- Targeting autophagy pathways offers potential for novel therapeutic strategies.
- Further research is needed to fully elucidate the complex interplay between autophagy and Pompe disease.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Lysosomal Hydrolases
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

